Title : Effect of fosinopril on cardiac and metabolic parameters in patients with NIDDM.

Pub. Date : 1994 Dec

PMID : 7882821






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: To determine whether the angiotensin-converting enzyme (ACE) inhibitor fosinopril can favorably alter cardiac function in non-insulin-dependent diabetes mellitus NIDDM) patients who have either normal blood pressure (BP) or mild, untreated hypertension. Fosinopril angiotensin I converting enzyme Homo sapiens
2 OBJECTIVE: To determine whether the angiotensin-converting enzyme (ACE) inhibitor fosinopril can favorably alter cardiac function in non-insulin-dependent diabetes mellitus NIDDM) patients who have either normal blood pressure (BP) or mild, untreated hypertension. Fosinopril angiotensin I converting enzyme Homo sapiens
3 RESEARCH DESIGN AND METHODS: Fifty-five NIDDM subjects with normal BP or mild, untreated hypertension were randomized to treatment with the ACE-inhibitor fosinopril or placebo for 6 months in a randomized, double-blind trial to determine the effect of fosinopril on echocardiographic measurements. Fosinopril angiotensin I converting enzyme Homo sapiens